Release Date: 07/03/12 12:37 Summary: Olmos Sale Bolsters Cash Price Sensitive: Yes Download Document 200.69KB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%